These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9668535)

  • 1. The role of recombinant human erythropoietin in the treatment of thalassemia.
    Rachmilewitz EA; Aker M
    Ann N Y Acad Sci; 1998 Jun; 850():129-38. PubMed ID: 9668535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
    Fucharoen S; Siritanaratkul N; Winichagoon P; Chowthaworn J; Siriboon W; Muangsup W; Chaicharoen S; Poolsup N; Chindavijak B; Pootrakul P; Piankijagum A; Schechter AN; Rodgers GP
    Blood; 1996 Feb; 87(3):887-92. PubMed ID: 8562958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
    el-Hazmi MA; al-Momen A; Warsy AS; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F
    Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
    Chaidos A; Makis A; Hatzimichael E; Tsiara S; Gouva M; Tzouvara E; Bourantas KL
    Acta Haematol; 2004; 111(4):189-95. PubMed ID: 15153710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of thalassemia on the response to recombinant human erythropoietin in dialysis patients.
    Cheng IK; Lu HB; Wei DC; Cheng SW; Chan CY; Lee FC
    Am J Nephrol; 1993; 13(2):142-8. PubMed ID: 8342581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
    Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP
    Ann N Y Acad Sci; 2005; 1054():250-6. PubMed ID: 16339672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients.
    Elalfy MS; Adly AA; Ismail EA; Elhenawy YI; Elghamry IR
    Eur J Haematol; 2013 Dec; 91(6):522-33. PubMed ID: 23927461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients.
    Galanello R; Barella S; Turco MP; Giagu N; Cao A; Dore F; Liberato NL; Guarnone R; Barosi G
    Blood; 1994 Jan; 83(2):561-5. PubMed ID: 7506955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant erythropoietin in thalassemic patients on dialysis.
    Lai KN; Wong KC; Li PK; Lui SF
    Am J Kidney Dis; 1992 Mar; 19(3):239-45. PubMed ID: 1553968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA; al-Momen A; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F; Warsy AS
    Acta Haematol; 1995; 94(3):128-34. PubMed ID: 7502628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.
    Bohl D; Bosch A; Cardona A; Salvetti A; Heard JM
    Blood; 2000 May; 95(9):2793-8. PubMed ID: 10779423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassaemia.
    Rachmilewitz EA; Aker M; Perry D; Dover G
    Br J Haematol; 1995 Jun; 90(2):341-5. PubMed ID: 7794754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea.
    Dover GJ
    Ann N Y Acad Sci; 1998 Jun; 850():80-6. PubMed ID: 9668530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
    de Franceschi L; Rouyer-Fessard P; Alper SL; Jouault H; Brugnara C; Beuzard Y
    Blood; 1996 Feb; 87(3):1188-95. PubMed ID: 8562946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea therapy in thalassemia.
    Loukopoulos D; Voskaridou E; Stamoulakatou A; Papassotiriou Y; Kalotychou V; Loutradi A; Cozma G; Tsiarta H; Pavlides N
    Ann N Y Acad Sci; 1998 Jun; 850():120-8. PubMed ID: 9668534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
    Perrine SP; Castaneda SA; Boosalis MS; White GL; Jones BM; Bohacek R
    Ann N Y Acad Sci; 2005; 1054():257-65. PubMed ID: 16339673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of hydroxyurea effects on fetal hemoglobin production in cultures of beta-thalassemia erythroid precursors.
    Amoyal I; Goldfarb A; Fibach E
    Hemoglobin; 2003 May; 27(2):77-87. PubMed ID: 12779269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Tumor Necrosis Factor-Alpha on Erythropoietin and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients.
    Tanyong DI; Panichob P; Kheansaard W; Fucharoen S
    Turk J Haematol; 2015 Dec; 32(4):304-10. PubMed ID: 26376749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
    Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
    Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient.
    Makis AC; Chaliasos N; Hatzimichael EC; Bourantas KL
    Ann Hematol; 2001 Aug; 80(8):492-5. PubMed ID: 11563599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.